Francesca Polverino1,2,3, Borja G Cosio4,5, Jaime Pons4,6, Maria Laucho-Contreras1, Paula Tejera7, Amanda Iglesias4, Angel Rios4, Andreas Jahn4, Jaume Sauleda4,5, Miguel Divo1,2, Victor Pinto-Plata1,2, Lynette Sholl8, Ivan O Rosas1,2, Alvar Agustí5,9, Bartolome R Celli1,2, Caroline A Owen1,2. 1. 1 Division of Pulmonary and Critical Care Medicine and. 2. 2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico. 3. 3 University of Parma, Parma, Italy. 4. 4 Research Unit, FISIB, IdISPa, and. 5. 5 Department of Respiratory Medicine, Hospital Son Espases, Ciber de Enfermedades Respiratorias (CIBERES), Mallorca, Spain. 6. 6 Immunology Department, Hospital Son Espases, Mallorca, Spain. 7. 7 Harvard School of Public Health, Boston, Massachusetts; and. 8. 8 Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 9. 9 Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, and CIBERES, FISIB, Mallorca, Spain.
Abstract
RATIONALE: Patients with chronic obstructive pulmonary disease (COPD) have increased pulmonary lymphoid follicle (LF) counts. B cell-activating factor of tumor necrosis factor family (BAFF) regulates B cells in health, but its role in COPD pathogenesis is unclear. OBJECTIVES: To determine whether BAFF expression in pulmonary LFs correlates with COPD severity, LF size or number, and/or readouts of B-cell function in LFs. METHODS: We correlated BAFF immunostaining in LFs in lung explants or biopsies from nonsmoking control subjects (NSC), smokers without COPD (SC), and patients with COPD with the number and size of LFs, and LF B-cell apoptosis, activation, and proliferation. We analyzed serum BAFF levels and BAFF expression in B cells in blood and bronchoalveolar lavage samples from the same subject groups. We assessed whether: (1) cigarette smoke extract (CSE) increases B-cell BAFF expression and (2) recombinant BAFF (rBAFF) rescues B cells from CSE-induced apoptosis by inhibiting activation of nuclear factor-κB (NF-κB). MEASUREMENTS AND MAIN RESULTS: Patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage IV COPD had increased numbers and larger pulmonary LFs than patients with GOLD stages I-II COPD and SC. We identified two main types of pulmonary LFs: (1) type A, the predominant type in GOLD stages I-II COPD and SC, characterized by abundant apoptotic but few BAFF-positive cells (mostly B cells); and (2) type B, the main type in GOLD stage IV COPD, characterized by abundant BAFF-positive cells but few apoptotic cells (mostly B cells). BAFF levels were also higher in blood and bronchoalveolar lavage B cells in patients with COPD versus NSC and SC. Surprisingly, rBAFF blocked CSE-induced B-cell apoptosis by inhibiting CSE-induced NF-κB activation. CONCLUSIONS: Our data support the hypothesis that B-cell BAFF expression creates a self-perpetuating loop contributing to COPD progression by promoting pulmonary B-cell survival and LF expansion.
RATIONALE: Patients with chronic obstructive pulmonary disease (COPD) have increased pulmonary lymphoid follicle (LF) counts. B cell-activating factor of tumor necrosis factor family (BAFF) regulates B cells in health, but its role in COPD pathogenesis is unclear. OBJECTIVES: To determine whether BAFF expression in pulmonary LFs correlates with COPD severity, LF size or number, and/or readouts of B-cell function in LFs. METHODS: We correlated BAFF immunostaining in LFs in lung explants or biopsies from nonsmoking control subjects (NSC), smokers without COPD (SC), and patients with COPD with the number and size of LFs, and LF B-cell apoptosis, activation, and proliferation. We analyzed serum BAFF levels and BAFF expression in B cells in blood and bronchoalveolar lavage samples from the same subject groups. We assessed whether: (1) cigarette smoke extract (CSE) increases B-cell BAFF expression and (2) recombinant BAFF (rBAFF) rescues B cells from CSE-induced apoptosis by inhibiting activation of nuclear factor-κB (NF-κB). MEASUREMENTS AND MAIN RESULTS:Patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage IV COPD had increased numbers and larger pulmonary LFs than patients with GOLD stages I-II COPD and SC. We identified two main types of pulmonary LFs: (1) type A, the predominant type in GOLD stages I-II COPD and SC, characterized by abundant apoptotic but few BAFF-positive cells (mostly B cells); and (2) type B, the main type in GOLD stage IV COPD, characterized by abundant BAFF-positive cells but few apoptotic cells (mostly B cells). BAFF levels were also higher in blood and bronchoalveolar lavage B cells in patients with COPD versus NSC and SC. Surprisingly, rBAFF blocked CSE-induced B-cell apoptosis by inhibiting CSE-induced NF-κB activation. CONCLUSIONS: Our data support the hypothesis that B-cell BAFF expression creates a self-perpetuating loop contributing to COPD progression by promoting pulmonary B-cell survival and LF expansion.
Entities:
Keywords:
B cell–activating factor of tumor necrosis factor family; autoimmunity; chronic obstructive pulmonary disease; cigarette smoke; lymphoid follicles
Authors: Miyo Ota; Bao H Duong; Ali Torkamani; Colleen M Doyle; Amanda L Gavin; Takayuki Ota; David Nemazee Journal: J Immunol Date: 2010-09-03 Impact factor: 5.422
Authors: N Khandelwal; J Simpson; G Taylor; S Rafique; A Whitehouse; J Hiscox; L A Stark Journal: Cell Death Differ Date: 2011-06-10 Impact factor: 15.828
Authors: Francesca Polverino; Melanie Doyle-Eisele; Jacob McDonald; Julie A Wilder; Christopher Royer; Maria Laucho-Contreras; Emer M Kelly; Miguel Divo; Victor Pinto-Plata; Joe Mauderly; Bartolome R Celli; Yohannes Tesfaigzi; Caroline A Owen Journal: Am J Pathol Date: 2014-12-24 Impact factor: 4.307
Authors: Leen J M Seys; Fien M Verhamme; Anja Schinwald; Hamida Hammad; Danen Mootoosamy Cunoosamy; Claudie Bantsimba-Malanda; Alan Sabirsh; Eileen McCall; Liz Flavell; Ronald Herbst; Sharen Provoost; Bart N Lambrecht; Guy F Joos; Guy G Brusselle; Ken R Bracke Journal: Am J Respir Crit Care Med Date: 2015-09-15 Impact factor: 21.405
Authors: Kristin J Cummings; Marcia L Stanton; Kathleen Kreiss; Randy J Boylstein; Ju-Hyeong Park; Jean M Cox-Ganser; M Abbas Virji; Nicole T Edwards; Leopoldo N Segal; Martin J Blaser; David N Weissman; Randall J Nett Journal: Occup Environ Med Date: 2020-03-04 Impact factor: 4.402
Authors: Gaëtane C Michaud; Colleen L Channick; Anica C Law; Jessica B McCannon; MaryEllen Antkowiak; Garth Garrison; David Sayah; Richard H Huynh; Anna K Brady; Rosemary Adamson; Hilary DuBrock; Praveen Akuthota; Chad Marion; Charles Dela Cruz; James A Town; Başak Çoruh; Carey C Thomson Journal: Ann Am Thorac Soc Date: 2016-07
Authors: Taotao Lao; Zhiqiang Jiang; Jeong Yun; Weiliang Qiu; Feng Guo; Chunfang Huang; John Dominic Mancini; Kushagra Gupta; Maria E Laucho-Contreras; Zun Zar Chi Naing; Li Zhang; Mark A Perrella; Caroline A Owen; Edwin K Silverman; Xiaobo Zhou Journal: Proc Natl Acad Sci U S A Date: 2016-07-21 Impact factor: 11.205